Stifel lowered the firm’s price target on Quipt Home Medical to C$8.50 from C$9.50 and keeps a Buy rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QIPT: